The clinical and laboratory characteristics of patients with chronic hepatitis B using current or past antiviral therapy in Korea: A multi-center, nation-wide, cross-sectional epidemiologic study

Gut and Liver

Volumn 6, Issue 2, 2012, Pages 241-248

  Choi, Moon Seok ^a   Sinn, Dong Hyun ^a   Kim, Su A ^a   Lee, Yil Seob ^b   Choi, Won ^b   Paik, Seung Woon ^a  

^a Sungkyunkwan University   (South Korea)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Epidemiology; Hepatitis B virus; Korea

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; CLEVUDINE; ENTECAVIR; INTERFERON; LAMIVUDINE; PEGINTERFERON; VIRUS DNA;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CHRONIC HEPATITIS; CLINICAL FEATURE; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HERBAL MEDICINE; HUMAN; INFECTION RATE; KOREA; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT CARE; PATIENT COMPLIANCE; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS HEPATITIS; VIRUS TRANSMISSION;

EID: 84860338765     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2012.6.2.241     Document Type: Article

References (22)

1. Chae HB, Kim JH, Kim JK, Yim HJ. Current status of liver diseases in Korea: Hepatitis B. Korean J Hepatol 2009;15 Suppl 6:S13-S24.
2. Sung JL. Hepatitis B virus eradication strategy for Asia. The Asian Regional Study Group. Vaccine 1990;8 Suppl:S95-S99. (Pubitemid 20154771)
3. Choe BH. The epidemiology and present status of chronic hepatitis B in Korean children. Korean J Pediatr 2008;51:696-703.
4. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002;17:457-462.
5. Shin BM, Yoo HM, Lee AS, Park SK. Seroprevalence of hepatitis B virus among health care workers in Korea. J Korean Med Sci 2006;21:58-62. (Pubitemid 43269287)
6. Lee MS, Kim DH, Kim H, et al. Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: A cohort study in Korea. Int J Epidemiol 1998;27:316-319. (Pubitemid 28203802)
7. Lee KS, Kim DJ; Korean Association for the Study of the Liver Guideline Committee. Management of chronic hepatitis B. Korean J Hepatol 2007;13:447-488.
8. Korean Liver Cancer Study Group; National Cancer Center, Korea. Practice guidelines for management of hepatocellular carcinoma 2009. Korean J Hepatol 2009;15:391-423.
9. Kwon SY, Lee CH. Epidemiology and prevention of hepatitis B virus infection. Korean J Hepatol 2011;17:87-95.
10. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-107. (Pubitemid 38365759)
11. Yun H, Kim D, Kim S, et al. High prevalence of HBV and HCV infection among intravenous drug users in Korea. J Med Virol 2008;80:1570-1575.
12. Kang J, Cho JH, Suh CW, et al. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol 2011;90:159-164.
13. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45: 507-539. (Pubitemid 46374607)
14. Feldman MS, Friedman LS, Brandt LJ. Sleisenger and Fordtran's gastrointestinal and liver disease: Pathology, diagnosis, management. 8th ed. Philadelphia: Saunders, 2006.
15. Marcellin P, Cadranel JF, Fontanges T, et al. High rate of adefovirlamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: Results of a national survey in 1730 patients. Eur J Gastroenterol Hepatol 2010;22:1290-1296.
16. Yim HJ, Hussain M, Liu Y, et al. Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology 2006;44:703-712. (Pubitemid 44433727)
17. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005. Hepatology 2006;43(2 Suppl 1):S173-S181.
18. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2001;34(4 Pt 1):617-624. (Pubitemid 32927983)
19. Choi MS, Yoo BC. Management of chronic hepatitis B with nucleoside or nucleotide analogues: A review of current guidelines. Gut Liver 2010;4:15-24.
20. Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology 2002;122:1554-1568.
21. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of chronic hepatitis B. J Hepatol 2009;50:227-242.
22. Lok AS, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology 2009;50:661-662.